$KMPH…. good news – #stocks chatter


$KMPH.... good news
Corium Secures $235 Million in Debt Financing

Proceeds to be Used to Commercialize AZSTARYS™ (serdexmethylphenidate [SDX] and dexmethylphenidate [d-MPH]) (CII) and Advance Pipeline

Corium, Inc.
Sep 27, 2021, 08:00 ET

BOSTON, Sept. 27, 2021 /PRNewswire/ -- Corium, Inc. (Corium), a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, today announces that it has closed on a $235 million term loan agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in specialty financing for life science and technology companies. Corium will receive an initial tranche of $100 million, and the remaining funds will be available in three additional tranches upon the achievement of c

This site uses Akismet to reduce spam. Learn how your comment data is processed.